| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00004872-200501000-00018 |
| P698 | PubMed publication ID | 15643130 |
| P2093 | author name string | Ichiro Nishio | |
| Toshio Imanishi | |||
| Takuzo Hano | |||
| P2860 | cites work | Extension of life-span by introduction of telomerase into normal human cells | Q24336088 |
| P433 | issue | 1 | |
| P921 | main subject | endothelium | Q111140 |
| cellular senescence | Q9075999 | ||
| P304 | page(s) | 97-104 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Journal of Hypertension | Q6295318 |
| P1476 | title | Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress | |
| P478 | volume | 23 |
| Q33895066 | A Tissue Engineered Model of Aging: Interdependence and Cooperative Effects in Failing Tissues. |
| Q57312495 | ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes |
| Q60182307 | ACE inhibition and glomerular repair: restructuring or regeneration? |
| Q34527232 | Adiponectin pretreatment counteracts the detrimental effect of a diabetic environment on endothelial progenitors |
| Q41880235 | Age-related Impairment of Vascular Structure and Functions |
| Q55062016 | Angelica sinensis polysaccharides inhibit endothelial progenitor cell senescence through the reduction of oxidative stress and activation of the Akt/hTERT pathway. |
| Q95360330 | Angiotensin II Attenuates the Bioactivities of Human Endothelial Progenitor Cells via Downregulation of β2-Adrenergic Receptor |
| Q37859447 | Angiotensin II and the vascular phenotype in hypertension |
| Q43273462 | Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway |
| Q26998758 | Angiotensin II, NADPH oxidase, and redox signaling in the vasculature |
| Q46944330 | Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways |
| Q40275746 | Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. |
| Q100430027 | Angiotensin inhibition and cellular senescence in the developing rat kidney |
| Q79811015 | Antioxidant protection: yet another function of endothelial progenitor cells? |
| Q34144269 | Arterial aging: a journey into subclinical arterial disease |
| Q33802557 | Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study |
| Q37802011 | At the stem of youth and health |
| Q22306336 | Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension |
| Q37783801 | Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy |
| Q35742909 | Circulating CD133(+)VEGFR2 (+) and CD34 (+)VEGFR2 (+) cells and arterial function in patients with beta-thalassaemia major |
| Q51127792 | Circulating endothelial cells, circulating endothelial progenitor cells, and von Willebrand factor in pregnancies complicated by hypertensive disorders. |
| Q37269391 | Circulating endothelial progenitor cells in cardiovascular disorders |
| Q62030629 | Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness |
| Q36310511 | Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects |
| Q45335007 | Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. |
| Q47967923 | ClC-3 deficiency prevents apoptosis induced by angiotensin II in endothelial progenitor cells via inhibition of NADPH oxidase |
| Q37661456 | Clinical implication of endothelial progenitor cells |
| Q26772290 | Critical Roles of Reactive Oxygen Species in Age-Related Impairment in Ischemia-Induced Neovascularization by Regulating Stem and Progenitor Cell Function |
| Q37780204 | Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction |
| Q46353246 | DJ-1 Alleviates Angiotensin II-Induced Endothelial Progenitor Cell Damage by Activating the PPARγ/HO-1 Pathway |
| Q36651392 | DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. |
| Q42473520 | Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism. |
| Q51069248 | Diesel exhaust particles impair endothelial progenitor cells, compromise endothelial integrity, reduce neoangiogenesis, and increase atherogenesis in mice. |
| Q37167510 | Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil |
| Q87345457 | Effects of Ca2+-activated potassium and inward rectifier potassium channel on the differentiation of endothelial progenitor cells from human peripheral blood |
| Q37430868 | Effects of acute and chronic endurance exercise on intracellular nitric oxide in putative endothelial progenitor cells: role of NAPDH oxidase |
| Q37290687 | Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside |
| Q38935695 | Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy. |
| Q38746041 | Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction? |
| Q36665257 | Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation |
| Q37645668 | Endothelial progenitor cell senescence--is there a role for estrogen? |
| Q37679623 | Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease? |
| Q33572269 | Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress |
| Q35765879 | Endothelial progenitor cells enter the aging arena |
| Q36933858 | Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box? |
| Q54382820 | Endothelial progenitor cells functionally express inward rectifier potassium channels. |
| Q54583808 | Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. |
| Q36603898 | Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases |
| Q37225174 | Endothelin 1 activation of endothelin A receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension |
| Q30446535 | Evidence for benefits of angiotensin receptor blockade beyond blood pressure control |
| Q35449304 | Genetics of leukocyte telomere length and its role in atherosclerosis |
| Q35210513 | Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes |
| Q42861228 | Impaired Endothelial Progenitor Cell Activity is Associated with Reduced Arterial Elasticity in Patients with Essential Hypertension |
| Q46621819 | Involvement of NADPH oxidases and non-muscle myosin light chain in senescence of endothelial progenitor cells in hyperlipidemia |
| Q46318091 | Involvement of angiotensin II-dependent vascular endothelial growth factor gene expression via NADPH oxidase in the retina in a type 2 diabetic rat model |
| Q37829386 | Is cellular senescence important in pediatric kidney disease? |
| Q42271787 | Long-term nicotine exposure induces dysfunction of mouse endothelial progenitor cells |
| Q39417862 | Losartan inhibits STAT1 activation and protects human glomerular mesangial cells from angiotensin II induced premature senescence |
| Q35990597 | Mechanisms involved in the aging-induced vascular dysfunction |
| Q34179571 | Mechanisms of vascular aging: new perspectives. |
| Q38625663 | Mesenchymal stem cells and chronic renal artery stenosis |
| Q59104729 | MicroRNAs and cardiovascular diseases |
| Q38599441 | Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder. |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q36052377 | Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy |
| Q90582750 | Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing |
| Q38569611 | PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN? |
| Q37269376 | Pharmacological approaches to improve endothelial repair mechanisms |
| Q84423967 | Potential mechanisms in angiotensin II-induced EPCs senescence |
| Q36743741 | Potential protective effects of telmisartan on renal function deterioration |
| Q33952603 | Prehypertension and endothelial progenitor cell function |
| Q36444277 | Premature senescence of endothelial cells: Methusaleh's dilemma |
| Q37053167 | Progenitor cells and vascular disease |
| Q37427910 | Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells |
| Q60921787 | Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation |
| Q46436434 | Puerarin reduces endothelial progenitor cells senescence through augmentation of telomerase activity |
| Q26851313 | Redox regulation of stem/progenitor cells and bone marrow niche |
| Q34703187 | Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome |
| Q37648491 | Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction |
| Q37707692 | Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR‑γ/HO‑1 pathways |
| Q36938449 | Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms |
| Q33587136 | Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis |
| Q54541213 | STAT1 mediates cellular senescence induced by angiotensin II and H₂O₂ in human glomerular mesangial cells. |
| Q88243444 | Senescent cells: a therapeutic target for cardiovascular disease |
| Q46824814 | Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats |
| Q37655211 | Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs |
| Q37999783 | Strategies to reverse endothelial progenitor cell dysfunction in diabetes |
| Q37311016 | Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells |
| Q37812423 | Telomere length and cardiovascular aging: The means to the ends? |
| Q54422743 | Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy. |
| Q34997466 | The NADPH oxidase Nox4 restricts the replicative lifespan of human endothelial cells |
| Q24605364 | The endothelium abridges insulin resistance to premature aging |
| Q42881647 | The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice |
| Q38006725 | The renin-angiotensin system, bone marrow and progenitor cells |
| Q38088106 | The roles of senescence and telomere shortening in cardiovascular disease |
| Q36940666 | Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase |
| Q37335759 | Vascular endothelial senescence: from mechanisms to pathophysiology. |
| Q35207893 | Vascular inflammation and endothelial dysfunction in experimental hypertension. |
| Q39174289 | Vascular precursor cells in tissue injury repair |
Search more.